Menu

Reading Material

Home
Reading Material

Material:

Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8

Author: Felix Fischer, Dario Zocholl, Geraldine Rauch, Brooke Levis, Andrea Benedetti, Brett Thombs, Matthias Rose, Polychronis Kostoulas 
10 May, 2023 
View Abstract

Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador

Author: Francesca Tamarozzi, Prof Ángel G Guevara, Mariella Anselmi, Yosselin Vicuña, Rosanna Prandi, Monica Marquez, Sandra Vivero, Francisco Robinzón Huerlo, Marcia Racines, Cristina Mazzi, Matthew Denwood, Dora Buonfrate 
11 April, 2023 
View Abstract

The epidemic volatility index, a novel early warning tool for identifying new waves in an epidemic

Author: Polychronis Kostoulas, Eletherios Meletis, Konstantinos Pateras, Paolo Eusebi, Theodoros Kostoulas, Luis Furuya-Kanamori, Niko Speybroeck, Matthew Denwood, Suhail A. R. Doi, Christian L. Althaus, Carsten Kirkeby, Pejman Rohani, Navneet K. Dhand, José L. Peñalvo, Lehana Thabane, Slimane BenMiled, Hamid Sharifi & Stephen D. Walter  
7 December, 2022 
View Abstract

A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research

Author: Taulant Muka, Marija Glisic, Jelena Milic, Sanne Verhoog, Julia Bohlius, Wichor Bramer, Rajiv Chowdhury & Oscar H. Franco  
6 December, 2022 
View Abstract

Using Bayes theorem to estimate positive and negative predictive values for continuously and ordinally scaled diagnostic tests

Author: Felix Fischer  
22 September, 2022 
View Abstract

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

www.cost.eu

CA18208

Harmony – COST Action CA18208 – Novel tools for test evaluation and disease prevalence estimation. Epidemiological studies assessing disease prevalence are critically important to both the identification and control of pathogens in humans and animals (including zoonosis and food borne outbreaks).

www.cost.eu/ca18208

Action Details

Grant Holder: University of Thessaly – GH Science
Start of Action: 25 October, 2019
End of Action: 24 October, 2023
Entry into force: 26 June, 2019
CSO approval date: 04 June, 2019
Action email: info@harmony-net.eu

Memorandum of Understanding (MoU)

© 2019-2023 Harmony – COST Action CA18208 – All rights reserved. Privacy Policy

Design by Boutik